MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Isoray Total Assets 2011-2026 | ISR
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Isoray
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 341 M | 97.9 M | 58.1 M | 70.4 M | 8.7 M | 9.42 M | 7.46 M | 12.3 M | 18.1 M | 23 M | 26.5 M | 7.06 M | 7.51 M | 7.89 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 341 M | 7.06 M | 49.7 M |
Quarterly Total Assets Isoray
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 295 M | 311 M | 341 M | 391 M | 386 M | 278 M | 97.9 M | 111 M | 120 M | 128 M | 58.1 M | 62.5 M | 64.4 M | 66.1 M | 67.3 M | 68.7 M | 70.4 M | 70.4 M | 15.5 M | 8.02 M | 8.7 M | 8.7 M | 8.93 M | 10.1 M | 9.42 M | 9.42 M | 11.9 M | 13.3 M | 7.46 M | 7.46 M | 9.38 M | 10.8 M | 12.3 M | 12.3 M | 15 M | 16.7 M | 18.1 M | 18.1 M | 20.7 M | 21.9 M | 23 M | 23 M | 24.6 M | 25.5 M | 26.5 M | 26.5 M | 8.19 M | 9.33 M | 7.06 M | 7.06 M | 8.72 M | 9.66 M | 7.51 M | 7.51 M | 8.45 M | 7.02 M | 7.89 M | 7.89 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 391 M | 7.02 M | 60.4 M |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
654 M | $ 29.85 | 1.05 % | $ 1.43 B |  USA |
 |
AngioDynamics
ANGO
|
280 M | $ 10.6 | -1.03 % | $ 433 M | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M | USA |
 |
Harvard Bioscience
HBIO
|
137 M | $ 0.47 | -4.15 % | $ 19.9 M | USA |
 |
Alcon
ALC
|
31.6 B | $ 77.32 | -1.5 % | $ 40.4 B |  Schweiz |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
ICU Medical
ICUI
|
4.05 B | $ 125.85 | -2.28 % | $ 3.1 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
InfuSystem Holdings
INFU
|
99.4 M | $ 9.31 | -0.85 % | $ 192 M | USA |
 |
iRhythm Technologies
IRTC
|
1.02 B | $ 113.0 | -1.46 % | $ 3.62 B | USA |
 |
Intuitive Surgical
ISRG
|
20.5 B | $ 472.16 | -1.48 % | $ 169 B | USA |
 |
The Cooper Companies
COO
|
12.4 B | $ 69.92 | -2.24 % | $ 13.9 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
Glaukos Corporation
GKOS
|
940 M | $ 97.02 | -0.79 % | $ 4.7 B | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 159.36 | -0.17 % | $ 45.8 B | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 59.92 | 0.72 % | $ 3.02 B | USA |
 |
electroCore
ECOR
|
16.1 M | $ 6.14 | -3.0 % | $ 33.9 K | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 175.49 | -0.01 % | $ 9.35 B | USA |
 |
Predictive Oncology
POAI
|
4.97 M | - | - | $ 31.1 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
20.1 M | $ 11.56 | -2.12 % | $ 28 M | USA |
 |
Repro Med Systems
KRMD
|
28.2 M | $ 4.28 | -0.7 % | $ 198 M | USA |
 |
Baxter International
BAX
|
20.1 B | $ 17.4 | -3.36 % | $ 8.93 B | USA |
 |
BioLife Solutions
BLFS
|
399 M | $ 18.36 | 1.16 % | $ 846 M | USA |
 |
Nephros
NEPH
|
11.9 M | $ 3.5 | -7.89 % | $ 36.4 M | USA |
 |
ResMed
RMD
|
5.1 B | $ 230.84 | -0.68 % | $ 33.7 B | USA |
 |
Retractable Technologies
RVP
|
161 M | $ 0.71 | 2.62 % | $ 21.3 M | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Merit Medical Systems
MMSI
|
2.69 B | $ 69.95 | 2.61 % | $ 4.14 B | USA |
 |
Envista Holdings Corporation
NVST
|
5.68 B | $ 24.61 | -3.26 % | $ 4.13 B | USA |
 |
STAAR Surgical Company
STAA
|
452 M | $ 18.84 | 2.45 % | $ 934 M | USA |
 |
Stereotaxis
STXS
|
52.3 M | $ 1.89 | 0.27 % | $ 172 M | USA |
 |
Teleflex Incorporated
TFX
|
6.95 B | $ 107.32 | -0.87 % | $ 4.79 B | USA |
 |
OraSure Technologies
OSUR
|
403 M | $ 2.97 | -3.88 % | $ 218 M | USA |
 |
LeMaitre Vascular
LMAT
|
616 M | $ 108.06 | 1.43 % | $ 2.45 B | USA |
 |
Utah Medical Products
UTMD
|
135 M | $ 63.28 | 1.02 % | $ 230 M | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 48.46 | 3.5 % | $ 159 M | USA |
 |
Microbot Medical
MBOT
|
8.33 M | $ 2.69 | -1.47 % | $ 27.4 M |  Israel |
 |
West Pharmaceutical Services
WST
|
4.27 B | $ 235.46 | 1.89 % | $ 17 B | USA |
 |
Repligen Corporation
RGEN
|
2.83 B | $ 114.2 | 0.39 % | $ 6.36 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.43 B | $ 11.54 | -2.2 % | $ 2.3 B | USA |
 |
Pulse Biosciences
PLSE
|
94.5 M | $ 21.57 | 1.27 % | $ 1.45 B | USA |
 |
STERIS plc
STE
|
10.1 B | $ 214.57 | 1.05 % | $ 21.2 B | USA |
 |
Milestone Scientific
MLSS
|
9.8 M | $ 0.28 | -3.75 % | $ 22.3 M | USA |